{"id":"https://openalex.org/W4367669136","doi":"https://doi.org/10.1002/cpt.2906","title":"European Conditional Marketing Authorization in a Rapidly Evolving Treatment Landscape: A Comprehensive Study of Anticancer Medicinal Products in 2006\u20132020","display_name":"European Conditional Marketing Authorization in a Rapidly Evolving Treatment Landscape: A Comprehensive Study of Anticancer Medicinal Products in 2006\u20132020","publication_year":2023,"publication_date":"2023-05-02","ids":{"openalex":"https://openalex.org/W4367669136","doi":"https://doi.org/10.1002/cpt.2906","pmid":"https://pubmed.ncbi.nlm.nih.gov/37129347"},"language":"en","primary_location":{"id":"doi:10.1002/cpt.2906","doi":"https://doi.org/10.1002/cpt.2906","is_oa":true,"landing_page_url":"https://doi.org/10.1002/cpt.2906","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cpt.2906","source":{"id":"https://openalex.org/S159852663","display_name":"Clinical Pharmacology & Therapeutics","issn_l":"0009-9236","issn":["0009-9236","1085-8733","1532-6535"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Pharmacology & Therapeutics","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cpt.2906","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5036228687","display_name":"Lourens T. Bloem","orcid":"https://orcid.org/0000-0002-0014-8625","observed_orcids":["https://orcid.org/0000-0002-0014-8625"]},"institutions":[{"id":"https://openalex.org/I193662353","display_name":"Utrecht University","ror":"https://ror.org/04pp8hn57","country_code":"NL","type":"education","lineage":["https://openalex.org/I193662353"]}],"countries":["NL"],"is_corresponding":true,"raw_author_name":"Lourens T. Bloem","raw_affiliation_strings":["Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht, The Netherlands"],"raw_orcid":"https://orcid.org/0000-0002-0014-8625","affiliations":[{"raw_affiliation_string":"Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht, The Netherlands","institution_ids":["https://openalex.org/I193662353"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047774552","display_name":"Jasmin Schelhaas","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I193662353","display_name":"Utrecht University","ror":"https://ror.org/04pp8hn57","country_code":"NL","type":"education","lineage":["https://openalex.org/I193662353"]},{"id":"https://openalex.org/I4210150351","display_name":"Medicines Evaluation Board","ror":"https://ror.org/05mv4rb84","country_code":"NL","type":"education","lineage":["https://openalex.org/I4210150351"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Jasmin Schelhaas","raw_affiliation_strings":["Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht, The Netherlands","Dutch Medicines Evaluation Board (CBG-MEB), Utrecht, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht, The Netherlands","institution_ids":["https://openalex.org/I193662353"]},{"raw_affiliation_string":"Dutch Medicines Evaluation Board (CBG-MEB), Utrecht, The Netherlands","institution_ids":["https://openalex.org/I4210150351"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026102294","display_name":"Luc\u00eda L\u00f3pez\u2010Anglada","orcid":"https://orcid.org/0000-0003-1727-8546","observed_orcids":["https://orcid.org/0000-0003-1727-8546"]},"institutions":[{"id":"https://openalex.org/I4210142787","display_name":"Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios","ror":"https://ror.org/043fs9135","country_code":"ES","type":"government","lineage":["https://openalex.org/I4210098440","https://openalex.org/I4210142787"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Luc\u00eda L\u00f3pez\u2010Anglada","raw_affiliation_strings":["Pharmacology and Clinical Assessment Division, Spanish Medicines Agency (AEMPS), Madrid, Spain"],"raw_orcid":"https://orcid.org/0000-0003-1727-8546","affiliations":[{"raw_affiliation_string":"Pharmacology and Clinical Assessment Division, Spanish Medicines Agency (AEMPS), Madrid, Spain","institution_ids":["https://openalex.org/I4210142787"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046938775","display_name":"Carla A. Herberts","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210150351","display_name":"Medicines Evaluation Board","ror":"https://ror.org/05mv4rb84","country_code":"NL","type":"education","lineage":["https://openalex.org/I4210150351"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Carla Herberts","raw_affiliation_strings":["Dutch Medicines Evaluation Board (CBG-MEB), Utrecht, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dutch Medicines Evaluation Board (CBG-MEB), Utrecht, The Netherlands","institution_ids":["https://openalex.org/I4210150351"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037880046","display_name":"Paula B. van Hennik","orcid":"https://orcid.org/0000-0002-6950-1458","observed_orcids":["https://orcid.org/0000-0002-6950-1458"]},"institutions":[{"id":"https://openalex.org/I4210150351","display_name":"Medicines Evaluation Board","ror":"https://ror.org/05mv4rb84","country_code":"NL","type":"education","lineage":["https://openalex.org/I4210150351"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Paula B. van Hennik","raw_affiliation_strings":["Dutch Medicines Evaluation Board (CBG-MEB), Utrecht, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dutch Medicines Evaluation Board (CBG-MEB), Utrecht, The Netherlands","institution_ids":["https://openalex.org/I4210150351"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5083816669","display_name":"Olli Tenhunen","orcid":"https://orcid.org/0009-0009-0802-1619","observed_orcids":["https://orcid.org/0009-0009-0802-1619"]},"institutions":[{"id":"https://openalex.org/I2799272722","display_name":"Oulu University Hospital","ror":"https://ror.org/045ney286","country_code":"FI","type":"healthcare","lineage":["https://openalex.org/I2799272722"]},{"id":"https://openalex.org/I4210150926","display_name":"Finnish Medicines Agency Fimea","ror":"https://ror.org/04mjpp490","country_code":"FI","type":"government","lineage":["https://openalex.org/I4210150926","https://openalex.org/I4210159665"]},{"id":"https://openalex.org/I98381234","display_name":"University of Oulu","ror":"https://ror.org/03yj89h83","country_code":"FI","type":"education","lineage":["https://openalex.org/I98381234"]}],"countries":["FI"],"is_corresponding":false,"raw_author_name":"Olli Tenhunen","raw_affiliation_strings":["Finnish Medicines Agency (Fimea), Helsinki, Finland","Medical Research Center Oulu, University of Oulu and Oulu University Hospital, Oulu, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Finnish Medicines Agency (Fimea), Helsinki, Finland","institution_ids":["https://openalex.org/I4210150926"]},{"raw_affiliation_string":"Medical Research Center Oulu, University of Oulu and Oulu University Hospital, Oulu, Finland","institution_ids":["https://openalex.org/I2799272722","https://openalex.org/I98381234"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":6,"corresponding_author_ids":["https://openalex.org/A5036228687"],"corresponding_institution_ids":["https://openalex.org/I193662353"],"apc_list":{"value":4000,"currency":"USD","value_usd":4000},"apc_paid":{"value":4000,"currency":"USD","value_usd":4000},"fwci":4.6935,"has_fulltext":false,"cited_by_count":27,"citation_normalized_percentile":{"value":0.9483824,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"114","issue":"1","first_page":"148","last_page":"160"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.75,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.75,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T13417","display_name":"Biomedical Ethics and Regulation","score":0.09300000220537186,"subfield":{"id":"https://openalex.org/subfields/2910","display_name":"Issues, ethics and legal aspects"},"field":{"id":"https://openalex.org/fields/29","display_name":"Nursing"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T14396","display_name":"Healthcare Regulation","score":0.05139999836683273,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/conditional-marketing-authorisation","display_name":"conditional marketing authorisation","score":0.9900000095367432},{"id":"https://openalex.org/keywords/anticancer-agents","display_name":"anticancer agents","score":0.7670000195503235},{"id":"https://openalex.org/keywords/unmet-medical-needs","display_name":"unmet medical needs","score":0.8500000238418579},{"id":"https://openalex.org/keywords/benefit-risk-balance","display_name":"benefit-risk balance","score":0.8849999904632568},{"id":"https://openalex.org/keywords/european-medicines-agency","display_name":"European Medicines Agency","score":0.8769999742507935},{"id":"https://openalex.org/keywords/orphan-drug-designation","display_name":"orphan drug designation","score":0.6029999852180481},{"id":"https://openalex.org/keywords/oncology-drug-regulation","display_name":"oncology drug regulation","score":0.5870000123977661},{"id":"https://openalex.org/keywords/access-to-medicines","display_name":"access to medicines","score":0.656000018119812}],"concepts":[{"id":"https://openalex.org/C2777589142","wikidata":"https://www.wikidata.org/wiki/Q6770899","display_name":"Marketing authorization","level":2,"score":0.7997472286224365},{"id":"https://openalex.org/C108759981","wikidata":"https://www.wikidata.org/wiki/Q788590","display_name":"Authorization","level":2,"score":0.7558461427688599},{"id":"https://openalex.org/C108170787","wikidata":"https://www.wikidata.org/wiki/Q3951828","display_name":"Agency (philosophy)","level":2,"score":0.5609952211380005},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5252227783203125},{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.4633750021457672},{"id":"https://openalex.org/C75480439","wikidata":"https://www.wikidata.org/wiki/Q1367466","display_name":"Orphan drug","level":2,"score":0.44138211011886597},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.4150211215019226},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.4142269492149353},{"id":"https://openalex.org/C162853370","wikidata":"https://www.wikidata.org/wiki/Q39809","display_name":"Marketing","level":1,"score":0.36658111214637756},{"id":"https://openalex.org/C512399662","wikidata":"https://www.wikidata.org/wiki/Q3505712","display_name":"Family medicine","level":1,"score":0.32405632734298706},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.1284472942352295},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.10598695278167725},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.10270845890045166},{"id":"https://openalex.org/C138885662","wikidata":"https://www.wikidata.org/wiki/Q5891","display_name":"Philosophy","level":0,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C111472728","wikidata":"https://www.wikidata.org/wiki/Q9471","display_name":"Epistemology","level":1,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C38652104","wikidata":"https://www.wikidata.org/wiki/Q3510521","display_name":"Computer security","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017277","descriptor_name":"Drug Approval","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D018570","descriptor_name":"Risk Assessment","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D040541","descriptor_name":"Marketing","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1002/cpt.2906","doi":"https://doi.org/10.1002/cpt.2906","is_oa":true,"landing_page_url":"https://doi.org/10.1002/cpt.2906","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cpt.2906","source":{"id":"https://openalex.org/S159852663","display_name":"Clinical Pharmacology & Therapeutics","issn_l":"0009-9236","issn":["0009-9236","1085-8733","1532-6535"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Pharmacology & Therapeutics","raw_type":"journal-article"},{"id":"pmid:37129347","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/37129347","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical pharmacology and therapeutics","raw_type":"Randomized Controlled Trial"},{"id":"pmh:oai:dspace.library.uu.nl:1874/429487","doi":null,"is_oa":true,"landing_page_url":"https://dspace.library.uu.nl/handle/1874/429487","pdf_url":null,"source":{"id":"https://openalex.org/S4306401649","display_name":"Utrecht University Repository (Utrecht University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I193662353","host_organization_name":"Utrecht University","host_organization_lineage":["https://openalex.org/I193662353"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Article"}],"best_oa_location":{"id":"doi:10.1002/cpt.2906","doi":"https://doi.org/10.1002/cpt.2906","is_oa":true,"landing_page_url":"https://doi.org/10.1002/cpt.2906","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cpt.2906","source":{"id":"https://openalex.org/S159852663","display_name":"Clinical Pharmacology & Therapeutics","issn_l":"0009-9236","issn":["0009-9236","1085-8733","1532-6535"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Pharmacology & Therapeutics","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.8048999905586243,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":false},"content_urls":{"pdf":"https://content.openalex.org/works/W4367669136.pdf"},"referenced_works_count":27,"referenced_works":["https://openalex.org/W1513425378","https://openalex.org/W1937020882","https://openalex.org/W2017441286","https://openalex.org/W2212551923","https://openalex.org/W2343598183","https://openalex.org/W2464447852","https://openalex.org/W2610311721","https://openalex.org/W2810237337","https://openalex.org/W2897458944","https://openalex.org/W2906556128","https://openalex.org/W2947203714","https://openalex.org/W2981519782","https://openalex.org/W3014378002","https://openalex.org/W3035947584","https://openalex.org/W3096014946","https://openalex.org/W3119846258","https://openalex.org/W3203286369","https://openalex.org/W3212056044","https://openalex.org/W4200431190","https://openalex.org/W4205385332","https://openalex.org/W4210502005","https://openalex.org/W4224112809","https://openalex.org/W4290791806","https://openalex.org/W4292367025","https://openalex.org/W4296698983","https://openalex.org/W4300861203","https://openalex.org/W4321597501"],"related_works":["https://openalex.org/W7221660850","https://openalex.org/W1513425378","https://openalex.org/W4410243331","https://openalex.org/W4406151201","https://openalex.org/W4390126590","https://openalex.org/W2545709967","https://openalex.org/W4405750494","https://openalex.org/W4412271110","https://openalex.org/W2810237337","https://openalex.org/W3212056044"],"abstract_inverted_index":{"Since":[0,67],"2006,":[1],"the":[2,55,62,85,107,113,195,204,219,226,233],"European":[3,108,196],"conditional":[4],"marketing":[5],"authorization":[6],"(CMA)":[7],"aims":[8],"to":[9,14,45,60,83,130,202],"facilitate":[10],"timely":[11],"patient":[12],"access":[13],"medicinal":[15,95,116,140,169],"products":[16,96,117,141,170],"for":[17,93,171],"which":[18,88,172],"there":[19],"is":[20],"an":[21],"unmet":[22,42,144,229],"medical":[23,43,145,230],"need":[24,231],"by":[25,147],"accepting":[26],"less":[27],"comprehensive":[28,51],"data":[29,52,65,186],"than":[30,72],"normally":[31],"required.":[32],"The":[33],"granting":[34],"of":[35,50,57,64,74,112,123,128,135,168,222,228],"CMA":[36,89,119,205],"requires":[37],"a":[38,149,173,207],"positive":[39],"benefit-risk":[40,234],"balance,":[41,235],"needs":[44,146],"be":[46],"fulfilled,":[47],"likely":[48],"submission":[49],"postauthorization,":[53],"and":[54,97,157,180,194,215,232,240],"benefit":[56],"immediate":[58],"availability":[59],"outweigh":[61],"risks":[63],"noncomprehensiveness.":[66],"its":[68],"first":[69],"use,":[70],"more":[71],"half":[73],"all":[75,124],"CMAs":[76,138,224],"represent":[77],"(hemato-)oncology":[78],"indications.":[79],"Therefore,":[80],"we":[81],"aimed":[82],"investigate":[84],"conditions":[86],"in":[87,120,237],"has":[90],"been":[91],"applied":[92],"anticancer":[94,115],"whether":[98],"they":[99],"have":[100,199],"changed":[101],"over":[102,153],"time.":[103],"We":[104],"retrospectively":[105],"assessed":[106],"public":[109],"assessment":[110],"reports":[111],"30":[114],"granted":[118,223],"2006-2020":[121],"(51%":[122],"59":[125],"CMAs).":[126],"Comparison":[127],"2006-2013":[129],"2014-2020":[131],"highlighted":[132],"increased":[133],"proportions":[134,167],"proactively":[136],"requested":[137],"(+40%),":[139],"that":[142,192],"addressed":[143],"providing":[148],"major":[150],"therapeutic":[151],"advantage":[152],"authorized":[154],"treatments":[155],"(+38%),":[156],"orphan":[158],"designated":[159],"indications":[160,239],"(+32%).":[161],"In":[162],"contrast,":[163],"it":[164],"showed":[165],"decreased":[166],"scientific":[174],"advisory":[175],"group":[176],"was":[177],"consulted":[178],"(-55%)":[179],"phase":[181,243],"III":[182],"randomized":[183],"controlled":[184],"trial":[185],"were":[187],"available":[188],"(-38%).":[189],"This":[190],"suggests":[191],"applicants":[193],"Medicines":[197],"Agency":[198],"learned":[200],"how":[201],"use":[203],"as":[206],"regulatory":[208],"tool,":[209],"among":[210],"others,":[211],"through":[212],"better":[213],"planning":[214],"proactive":[216],"interaction.":[217],"However,":[218],"increasing":[220],"number":[221],"complicates":[225],"establishment":[227],"especially":[236],"crowded":[238],"when":[241],"only":[242],"II":[244],"uncontrolled":[245],"trials":[246],"are":[247],"available.":[248]},"counts_by_year":[{"year":2026,"cited_by_count":12},{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":9},{"year":2023,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-05-03T00:00:00"}